Can Pentraxin-3 be a Candidate Marker in the Follow-Up of the Patients With Behçet’s Disease?
| Autor: | Esra Ekiz, Banu Mesci, Esen Kasapoğlu Günal, Banu Isbilen Basok, Mukaddes Kavala, Ferruh Kemal Isman, Aytekin Oğuz, Hatice Gül Sağun, Gökhan Gönenli |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
030203 arthritis & rheumatology
medicine.medical_specialty business.industry Mucocutaneous zone Area under the curve Mean age Behcet's disease 030204 cardiovascular system & hematology medicine.disease Gastroenterology Article 03 medical and health sciences 0302 clinical medicine Rheumatology Internal medicine Inflammatory marker Medicine In patient business Uveitis Pentraxin-3 |
| Zdroj: | Archives of Rheumatology. 32:91-95 |
| ISSN: | 2148-5046 |
| DOI: | 10.5606/archrheumatol.2017.6129 |
| Popis: | Objectives This study aims to assess the level of pentraxin-3 (PTX-3) as an inflammatory marker and compare it with C-reactive protein (CRP) levels in patients with Behcet's disease (BD). Patients and methods Forty-two patients with BD (15 males, 27 females; mean age 39.7±8.6 years; range 20 to 64 years) and 42 age- and sex- matched healthy controls (14 males, 28 females; mean age 40.8±8.2 year; range 25 to 60 years) were included in the study. Serum CRP and plasma PTX-3 levels were measured. Subgroup analyses were performed according to clinical manifestations of patients with BD. Results Both PTX-3 and CRP levels were significantly higher in patients with BD than controls (1.33±0.29 vs 0.85±0.12, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|